全文获取类型
收费全文 | 2403510篇 |
免费 | 183274篇 |
国内免费 | 12609篇 |
专业分类
耳鼻咽喉 | 32175篇 |
儿科学 | 76213篇 |
妇产科学 | 65624篇 |
基础医学 | 341806篇 |
口腔科学 | 65246篇 |
临床医学 | 219193篇 |
内科学 | 460500篇 |
皮肤病学 | 54269篇 |
神经病学 | 188011篇 |
特种医学 | 92847篇 |
外国民族医学 | 730篇 |
外科学 | 354582篇 |
综合类 | 72751篇 |
现状与发展 | 32篇 |
一般理论 | 724篇 |
预防医学 | 180021篇 |
眼科学 | 54977篇 |
药学 | 184915篇 |
128篇 | |
中国医学 | 13185篇 |
肿瘤学 | 141464篇 |
出版年
2021年 | 23661篇 |
2019年 | 22103篇 |
2018年 | 29739篇 |
2017年 | 23750篇 |
2016年 | 26017篇 |
2015年 | 30541篇 |
2014年 | 41694篇 |
2013年 | 57973篇 |
2012年 | 79049篇 |
2011年 | 83770篇 |
2010年 | 50719篇 |
2009年 | 46990篇 |
2008年 | 74928篇 |
2007年 | 79124篇 |
2006年 | 79523篇 |
2005年 | 76131篇 |
2004年 | 71645篇 |
2003年 | 68878篇 |
2002年 | 65950篇 |
2001年 | 120837篇 |
2000年 | 123484篇 |
1999年 | 103081篇 |
1998年 | 28443篇 |
1997年 | 25744篇 |
1996年 | 25329篇 |
1995年 | 23918篇 |
1994年 | 21815篇 |
1993年 | 20265篇 |
1992年 | 76760篇 |
1991年 | 73518篇 |
1990年 | 71274篇 |
1989年 | 68195篇 |
1988年 | 62227篇 |
1987年 | 60508篇 |
1986年 | 56872篇 |
1985年 | 53771篇 |
1984年 | 40108篇 |
1983年 | 33760篇 |
1982年 | 19731篇 |
1979年 | 35344篇 |
1978年 | 24458篇 |
1977年 | 21040篇 |
1976年 | 19109篇 |
1975年 | 20512篇 |
1974年 | 24355篇 |
1973年 | 23467篇 |
1972年 | 22255篇 |
1971年 | 20533篇 |
1970年 | 19231篇 |
1969年 | 18187篇 |
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
51.
52.
M.-A. Fauroux A. Germa P. Tramini C. Nabet 《Revue d'épidémiologie et de santé publique》2019,67(4):223-231
BackgroundThe aim of this study was to estimate the prevalence of dental prosthetic treatment and to investigate the demographic, social, economic and medical factors associated with the use of fixed and removable dentures in a representative sample of adults living in France.MethodsThe data were obtained from the 2002–2003 Decennial Health Survey, a cross-sectional study of a representative sample of the population living in France, which included 29,679 adults. Information was collected by interview. The variables collected were fixed denture, removable denture, age, gender, number of children, area of residence, nationality, educational attainment, family social status, employment status, annual household income per capita, supplementary insurance, chronic disease, eyesight problems/glasses, hearing problems/hearing aids. Multinomial logistic regression models were used to study the relationship between prosthetic treatment and demographic, socioeconomic and medical characteristics unadjusted, adjusted for age and adjusted for all the characteristics.ResultsThe prevalence of prosthetic treatment was 34.6% (95% confidence interval (CI): [34.1; 35.2]) for fixed prosthetic dentures and 13.8% (95% CI: [13.4; 14.2]) for removable prosthetic dentures. We showed a gradient between educational attainment and removable dentures; the odds ratio adjusted for all the variables (aOR) associated with no or primary education compared to post-secondary education was 2.56; 95% CI: [2.09; 3.13]. When annual household income per capita was low, subjects were less likely to report fixed dentures (aOR = 0.68; 95% CI: [0.62; 0.75]) than those with high annual household income per capita. Individuals without insurance less often reported fixed dentures than those with private insurance. Those reporting chronic disease were less likely to report fixed dentures (aOR = 0.87; 95% CI: [0.79; 0.95]) but more likely to report removable dentures (aOR = 1.29; 95% CI: [1.17; 1.43]) than those without chronic disease.ConclusionThis study reveals social, economic and medical inequalities in fixed and removable prosthetic treatment among adults in France. 相似文献
53.
54.
Jamie C. Capuzza 《Journal of Children and Media》2020,14(3):324-342
ABSTRACT This project examined 55 picture books featuring transgender, gender expansive or genderqueer protagonists or narrators published between 2008 and 2018. The purpose of the study was to determine how this genre of children’s literature supports and challenges four gender assumptions: the gender binary, gender essentialism, sex/gender congruency and gender stability. Additionally, this critical analysis explored misgendering within this genre and themes of social rejection and acceptance. Protagonists and narrators were permitted a degree of gender nonconformity, however, the majority of picture books missed opportunities for a more complete exploration of gender possibilities. 相似文献
55.
目的:探索以系统化、标准化的新型冠状病毒核酸检测为核心和重要组成部分,建立适合于眼科医院新冠疫情精准防控切实可行的防控体系。方法:系列病例研究。自2020年2月24日至3月2日期间,以标准化病毒核酸检测联合血常规、C反应蛋白(CRP)、血清淀粉样蛋白A(SAA)等检测作为所有眼科手术患者术前筛查常规检测项目,同时也为返岗员工提供病毒核酸检测。设计调查问卷了解受检者对鼻咽拭子采样的接受度以及核酸检测结果对其心理状态的影响。结果:99例患者血液学检测结果有一定的异常比例,其中SAA检测结果增高13例,淋巴细胞计数减低12例、增高5例,白细胞计数增高11例、减低1例,CRP增高2例,新型冠状病毒核酸检测均阴性。33例本院职工新型冠状病毒核酸检测均阴性。12%的受访者对鼻咽拭子采样接受度评分较低。受检者在核酸检测前后思想压力评分较高的比例分别为46.7%和6.7%。结论:该项举措一方面为术前新冠病毒肺炎筛查及鉴别诊断提供了客观依据,很大程度上排除了隐性无症状感染者传播的可能,有利于减少二次传播的风险,降低院内交叉感染的概率;另一方面,核酸检测阴性结果有利于调整患者术前的心理状态并缓解医护人员在疫情防控期间的心理压力。 相似文献
56.
57.
58.
59.
60.
Liam Masterson James Howard Jazmina Gonzalez-Cruz Christopher Jackson Catherine Barnett Lewis Overton Howard Liu Rahul Ladwa Fiona Simpson Margie McGrath Ben Wallwork Terry Jones Christian Ottensmeier Melvin L.K. Chua Chris Perry Rajiv Khanna Benedict Panizza Sandro Porceddu Matt Lechner 《International journal of cancer. Journal international du cancer》2020,146(8):2305-2314
Now is an exciting era of development in immunotherapy checkpoint inhibitors and their effect on the treatment of NPC. While the general prognosis of R/M disease is poor, immunotherapy offers some promise in a malignancy associated with EBV and characterized by a peritumoural immune infiltrate. Our study aims to review past and on-going clinical trials of monoclonal antibody therapies against the checkpoint inhibitors (e.g. PD1 and CTLA-4), in R/M NPC. All randomized and nonrandomized controlled trials involving immune checkpoint inhibitor interventions for treatment of NPC were included in the study. We utilized a validated “risk of bias” tool to assess study quality. Four separate Phase I–II trials report the potential of PD1 inhibitor treatment for patients with NPC. Within the observed groups, camrelizumab combined with chemotherapy achieved an objective response in 91% of patients as first-line treatment for metastatic NPC (PFS 68% at 1-year) but this was associated with a high rate of grade >3 adverse events (87%; CTCAE version 4.03). The remaining three studies focused on recurrent NPC disease in patients who had received at least one line of prior chemotherapy. Within this group, camrelizumab monotherapy achieved an objective response in 34% of patients (PFS 27% at 1-year; range across all three studies 20.5–34%). No NPC trial has yet reported on specific outcomes for non-PD1 checkpoint inhibitors but 11 on-going studies include alternative targets (e.g. PD-L1/CTLA-4) as combination or monotherapy treatments. In considering checkpoint immunotherapies for NPC, initial results show promise for anti-PD1 interventions. Further phase I–III trials are in progress to clarify clinical outcomes, fully determine safety profiles, and optimize drug combinations and administration schedules. 相似文献